21.01.2026
Artificial intelligence in medicine: the turning point is here.
Five years ago, AI in medicine sounded like a promise. Today, it’s becoming an industry.
Google has just crossed a decisive threshold, Isomorphic Labs is preparing clinical trials, and AI-designed drugs could shrink a 15-year process to a matter of months. This is no longer about algorithms supporting research – it’s about redefining how medicine is discovered, tested, and delivered.
Behind the technology lies a massive economic shift: healthcare, data, code, and capital are converging. For patients, it means faster treatments. For pharma, a new operating model. For investors, a frontier that is just opening.
Watch the video by John Plassard, Partner & Head of Investment Strategy at Cité Gestion!
More articles
28.04.2026
What is really happening in the global automotive industry?
China is rapidly transforming the global automotive industry by leading innovation and scale in electric vehicles, challenging established players and creating new investment opportunities.
23.04.2026
Welcome to Claudia Marigliano and Pedro Hernandez!
We are pleased to announce the arrival of Claudia Marigliano and Pedro Hernandez at Cité Gestion.
Read more14.04.2026
How do oil price shocks affect inflation over time?
Oil shocks do not strike all at once: they develop gradually, and by the time their full impact becomes apparent, the situation is already well underway.
Read more09.04.2026
Zermatters x Cité Gestion
As Zermatt’s ski season comes to a close, we proudly carry forward our enduring partnership with Zermatters, embracing a new season of alpine experiences and shared ambitions.
Read more01.04.2026
How to navigate uncertainty?
Volatility is shaping markets, but investors may be underestimating future risks.
Read more30.03.2026
Appointment of two new partners at Cité Gestion
We are delighted to announce the appointment of Africa Bootello and Joëlle Garcia as partners.
Read more